Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition

  • Authors:
    • Tianfeng Liu
    • Peishu Liu
    • Feng Ding
    • Nina Yu
    • Shihong Li
    • Surong Wang
    • Xiaofei Zhang
    • Xiangxiu Sun
    • Ying Chen
    • Feng Wang
    • Yunhe Zhao
    • Bo Li
  • View Affiliations

  • Published online on: December 12, 2014     https://doi.org/10.3892/or.2014.3672
  • Pages: 861-867
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ampelopsin has displayed anticancer activity in several types of cancers. However, no evidence has been reported for the direct effect of ampelopsin on ovarian cancer cell migration and invasion, and the underling mechanisms have not yet been clearly established. The aim of the present study was to investigate the influence of ampelopsin on the migration and invasion of ovarian cancer. Proliferation and viability of the ovarian cancer cells were detected by MTT assay. Migration and invasion of the cells were detected, respectively, by scratch wound healing assay and Transwell assay. The expression levels of epithelial-to-mesenchymal transition (EMT) markers were detected at the protein level after stimulation with ampelopsin. Then, the expression levels of NF-κB and p-IκBα were detected with western blot analysis. Meanwhile, an inhibitor of NF-κB was used to investigate the effect of ampelopsin. Finally, the expression of Snail was also detected. Proliferation, migration and invasion of the A2780 cells were all inhibited following the application of ampelopsin. Ampelopsin upregulated E-cadherin and downregulated N-cadherin and vimentin in a concentration- and time-dependent manner. Ampelopsin also exerted its ability to suppress the nuclear translocation of the NF-κB pathway. Administration of the inhibitor BAY11‑7082 confirmed the roles of NF-κB in the expression of EMT markers and its transcription factor. These results demonstrated that ampelopsin inhibited EMT and reduced the invasion of ovarian cancer cells via the NF-κB/Snail pathway.
View Figures
View References

Related Articles

Journal Cover

February-2015
Volume 33 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu T, Liu P, Ding F, Yu N, Li S, Wang S, Zhang X, Sun X, Chen Y, Wang F, Wang F, et al: Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition. Oncol Rep 33: 861-867, 2015
APA
Liu, T., Liu, P., Ding, F., Yu, N., Li, S., Wang, S. ... Li, B. (2015). Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition. Oncology Reports, 33, 861-867. https://doi.org/10.3892/or.2014.3672
MLA
Liu, T., Liu, P., Ding, F., Yu, N., Li, S., Wang, S., Zhang, X., Sun, X., Chen, Y., Wang, F., Zhao, Y., Li, B."Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition". Oncology Reports 33.2 (2015): 861-867.
Chicago
Liu, T., Liu, P., Ding, F., Yu, N., Li, S., Wang, S., Zhang, X., Sun, X., Chen, Y., Wang, F., Zhao, Y., Li, B."Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition". Oncology Reports 33, no. 2 (2015): 861-867. https://doi.org/10.3892/or.2014.3672